Phio Pharmaceuticals Corp. Business Finance Contracts & Agreements
60 Contracts & Agreements
- Investment Agreements (1 contract)
- Purchase Agreements (17)
- Registration Rights Agreements (4)
- Stock Agreements (6)
- Underwriting Agreements (7)
- Warrant Agreements (25)
- Form of Series A Common Stock Warrant, dated June 2, 2023 (Filed With SEC on June 2, 2023)
- Form of Series B Common Stock Warrant, dated June 2, 2023 (Filed With SEC on June 2, 2023)
- Form of Pre-funded Common Stock Warrant, dated June 2, 2023 (Filed With SEC on June 2, 2023)
- Form of Securities Purchase Agreement, dated May 31, 2023, by and between the Company and each of the Purchasers signatory thereto (Registered Direct Offering) (Filed With SEC on June 2, 2023)
- Form of Securities Purchase Agreement, dated May 31, 2023, by and between the Company and each of the Purchasers signatory thereto (PIPE Private Placement) (Filed With SEC on June 2, 2023)
- Form of Registration Rights Agreement, dated May 31, 2023, by and between the Company and each of the Purchasers signatory thereto (Filed With SEC on June 2, 2023)
- Form of Series A Common Stock Warrant, dated April 20, 2023 (Filed With SEC on April 20, 2023)
- Form of Series B Common Stock Warrant, dated April 20, 2023 (Filed With SEC on April 20, 2023)
- Form of Existing Warrant Amendment, dated April 18, 2023 (Filed With SEC on April 20, 2023)
- Form of Securities Purchase Agreement, dated April 18, 2023, by and between the Company and each of the Purchasers signatory thereto (Filed With SEC on April 20, 2023)
- Subscription and Investment Representation Agreement, dated November 16, 2022, by and between Phio Pharmaceuticals Corp. and the purchaser signatory thereto (Filed With SEC on November 16, 2022)
- Form of Placement Agent Warrant (Filed With SEC on February 17, 2021)
- Form of Securities Purchase Agreement, dated February 12, 2021, by and between the Company and the Purchasers signatory therein (Filed With SEC on February 17, 2021)
- Form of Common Stock Warrant (Filed With SEC on January 25, 2021)
- Form of Pre-Funded Common Stock Warrant (Filed With SEC on January 25, 2021)
- Form of Securities Purchase Agreement, dated January 21, 2021, by and between the Company and the Purchasers signatory therein (Filed With SEC on January 25, 2021)
- Form of Registration Rights Agreement, dated January 21, 2021, by and between the Company and the Purchasers signatory therein (Filed With SEC on January 25, 2021)
- Form of Common Stock Warrant (Filed With SEC on April 2, 2020)
- Securities Purchase Agreement, dated March 31, 2020, by and between the Company and the Purchasers signatory therein (Filed With SEC on April 2, 2020)
- Underwriting Agreement, dated as of February 11, 2020, between Phio Pharmaceuticals Corp. and H.C. Wainwright & Co., LLC, as representative of the underwriters named therein (Filed With SEC on February 13, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on February 13, 2020)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on February 13, 2020)
- Form of Underwriter Common Stock Purchase Warrant (Filed With SEC on February 13, 2020)
- Form of Common Stock Warrant (Filed With SEC on February 6, 2020)
- Securities Purchase Agreement, dated February 4, 2020, by and between the Company and the Purchasers signatory therein (Filed With SEC on February 6, 2020)
- Form of Underwriting Agreement (Filed With SEC on January 31, 2020)
- Form of Warrant (Filed With SEC on January 31, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on January 31, 2020)
- Form of Underwriter Warrant (Filed With SEC on January 31, 2020)
- First Amendment to Purchase Agreement by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 30, 2019)
- Purchase Agreement, dated as of August 7, 2019 by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 9, 2019)
- Registration Rights Agreement, dated as of August 7, 2019, by and between Phio Pharmaceuticals Corp. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 9, 2019)
- Amendment No. 2 to Cauwenbergh Non-Plan Stock Compensation Election Agreement (Filed With SEC on February 15, 2019)
- Amendment No. 1 to Cauwenbergh Non-Plan Stock Compensation Election Agreement (Filed With SEC on December 21, 2018)
- Underwriting Agreement, dated as of October 1, 2018, between RXi Pharmaceuticals Corporation and H.C. Wainwright & Co., LLC, as representative of the underwriters named therein (Filed With SEC on October 5, 2018)
- Form of Underwriter Warrant (Filed With SEC on October 5, 2018)
- Form of Underwriting Agreement (Filed With SEC on September 28, 2018)
- Form of Warrant (Filed With SEC on September 28, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on September 28, 2018)
- Non-Plan Stock Compensation Election and Terms and Conditions (Filed With SEC on September 4, 2018)
